Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries

<table>Flowchart of patients included in each stage of HIV care. ART, antiretroviral therapy; * 46 patients having a first CD4 cell count &lt;250 cells/<i>μ</i>L were excluded because the CD4 count determination was performed after November 4th 2011.</table>

Interdisciplinary Perspectives on Infectious Diseases

fig1

Figure 1

Figure 1: Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries 

Figure 1 | Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries 